News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Astellas Gene Therapies
NEWS
JOBS
IN THE PRESS
NEWS
Business
San Francisco’s Audentes Appoints Three Execs Amidst Rumors of an IPO
September 29, 2015
·
3 min read
Deals
San Francisco’s Audentes Inks Deal to Buy Cardiogen Sciences
September 1, 2015
·
2 min read
Biotech Bay
San Francisco’s Audentes Therapeutics Rakes In $42.5 Million Series B
December 2, 2014
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
December 19, 2024
·
7 min read
Press Releases
Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
December 19, 2024
·
7 min read
Biotech Bay
Audentes Therapeutics Expands Mission, Becomes Astellas Gene Therapies
March 31, 2021
·
4 min read
Biotech Bay
Audentes Therapeutics Announces FDA Lifts Hold on ASPIRO Clinical Trial of AT132 for Treatment of X-Linked Myotubular Myopathy (XLMTM)
December 24, 2020
·
5 min read
Biotech Bay
Audentes Therapeutics Provides Update on the ASPIRO Clinical Trial Evaluating AT132 in Patients with X-linked Myotubular Myopathy
August 21, 2020
·
4 min read
Business
Audentes Therapeutics Appoints Julie Person as Senior Vice President, Human Resources
April 21, 2020
·
2 min read
Bio NC
Audentes Therapeutics Announces Plans to Build New State-of-the-Art Gene Therapy Manufacturing Facility in Sanford, North Carolina
February 18, 2020
·
3 min read
Deals
Astellas Completes Acquisition of Audentes Therapeutics
January 15, 2020
·
6 min read
Deals
Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics
December 2, 2019
·
12 min read
Business
Audentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 7, 2019
·
8 min read
